Erratum: Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse model.

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
11 Jun 2024
Historique:
medline: 29 4 2024
pubmed: 29 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

[This corrects the article DOI: 10.1016/j.omtn.2023.04.004.].

Identifiants

DOI: 10.1016/j.omtn.2024.102189 PMID: 38681817 PMC: PMC11046998
pubmed: 38681817
doi: 10.1016/j.omtn.2024.102189
pii: S2162-2531(24)00076-3
pmc: PMC11046998
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

102189

Commentaires et corrections

Type : ErratumFor

Informations de copyright

© 2024 The Author(s).

Auteurs

Vanessa Zancanella (V)

Astrid Vallès (A)

Jolanda M P Liefhebber (JMP)

Lieke Paerels (L)

Carlos Vendrell Tornero (CV)

Hendrina Wattimury (H)

Tom van der Zon (T)

Kristel van Rooijen (K)

Monika Golinska (M)

Tamar Grevelink (T)

Erich Ehlert (E)

Elsbet Jantine Pieterman (EJ)

Nanda Keijzer (N)

Hans Marinus Gerardus Princen (HM)

Geurt Stokman (G)

Ying Poi Liu (YP)

Classifications MeSH